Patent · US Active

Screening method

US9956223B2 · kind B2 · utility

11Cited by

5References

9Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Martin Ebeling · Weil am Rhein, DE
Friedrich Metzger · Glückstadt, DE
Manaswini Sivaramakrishnan · Basel, CH

Key dates

Filing date	Feb 19, 2016
Grant date	May 1, 2018
Priority date	—
Expiry date	Feb 19, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention discloses a screening method for the identification of new compounds for use in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.